HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Tuesday, 16 November 2010

Recently published CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  30 papers were listed this time.  Here's a handful:
  • Jit M, et al. The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales. Vaccine. 2010 Nov 2. [Epub ahead of print] PMID: 21055501 
  • Carr BI, et al. Economic evaluation of sorafenib in unresectable hepatocellular carcinoma. J Gastroenterol Hepatol. 2010 Nov;25(11):1739-46. PMID: 21039835
  • Hayashino Y, et al. Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease. Diabetes Res Clin Pract. 2010 Nov;90(2):154-9. Epub 2010 Aug 13.PMID: 20708813
  • Ivergård M, et al. Identifying cost-effective treatment with raloxifene in postmenopausal women using risk algorithms for fractures and invasive breast cancer. Bone. 2010 Nov;47(5):966-74. Epub 2010 Aug 3.PMID: 20691296 
  • Neilson AR, et al. Cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in Germany. Rheumatology (Oxford). 2010 Nov;49(11):2122-34. Epub 2010 Jul 26. PMID: 20660498 
  • Matter-Walstra KW, et al. Trastuzumab beyond progression: a cost-utility analysis. Ann Oncol. 2010 Nov;21(11):2161-8. Epub 2010 May 5.PMID: 20444849